You’re offline. This is a read only version of the page.
Skip to main content
Educational Library
Toggle navigation
Home
EBMT Exam
EBMT Education
Search
MF Risk Calculator
Sign in
EBMT-EHA 6th European CAR T...
Seven-Day Vein-to-Vein Poin...
Seven-Day Vein-to-Vein Point-of-Care–Manufactured CD19 CAR T-Cell Therapy (GLPG5201) in R/R CLL Including Richter Transformation: Results from the Phase 1 Euplagia-1 Trial
To Bridge or not to Bridge before CAR T-cell therapy
Anna Dodero
16/02/2024
Open Document
